tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Eton Pharmaceuticals Reports Strong Q3 Growth Amid Challenges
PremiumCompany AnnouncementsEton Pharmaceuticals Reports Strong Q3 Growth Amid Challenges
3M ago
Eton Pharmaceuticals: Promising Growth Trajectory with Strong Revenue Performance and Strategic Expansions Justifying Buy Rating
Premium
Ratings
Eton Pharmaceuticals: Promising Growth Trajectory with Strong Revenue Performance and Strategic Expansions Justifying Buy Rating
3M ago
Eton Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
Eton Pharmaceuticals Reports Strong Q3 2025 Growth
3M ago
Eton Pharmaceuticals sees reaching annual revenue run rate of $80M in Q3
PremiumThe FlyEton Pharmaceuticals sees reaching annual revenue run rate of $80M in Q3
6M ago
Eton Pharmaceuticals’ ET-600 Launch and Strategic Expansion Drive Buy Rating
Premium
Ratings
Eton Pharmaceuticals’ ET-600 Launch and Strategic Expansion Drive Buy Rating
7M ago
Eton Pharmaceuticals’ New Drug Application Accepted by FDA
Premium
Company Announcements
Eton Pharmaceuticals’ New Drug Application Accepted by FDA
7M ago
Eton Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsEton Pharmaceuticals Holds Annual Stockholders Meeting
8M ago
Eton Pharmaceuticals price target raised to $35 from $33 at H.C. Wainwright
Premium
The Fly
Eton Pharmaceuticals price target raised to $35 from $33 at H.C. Wainwright
8M ago
Eton Pharmaceuticals: Buy Rating Affirmed on Khindivi’s FDA Approval and Strong Revenue Growth Prospects
Premium
Ratings
Eton Pharmaceuticals: Buy Rating Affirmed on Khindivi’s FDA Approval and Strong Revenue Growth Prospects
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100